Filtered By:
Condition: Hypertension
Management: Food and Drug Administration (FDA)

This page shows you your search results in order of relevance. This is page number 2.

Order by Relevance | Date

Total 49 results found since Jan 2013.

Ritalin Could Trigger Heart Problems In Children
Ritalin and similar forms of ADHD medication may trigger abnormal heart rhythms and increase heart attack risk in some children soon after they start taking the drug, according to a new study.  This connection was especially true for children who were born with heart disease. According to the study, published in the British medical journal BMJ, kids had an increased risk of heart attack between eight and 56 days after starting methylphenidate, a stimulant most commonly sold as Ritalin, although this heightened risk didn’t reach statistical significance. The researchers could find no evidence of a heightened...
Source: Science - The Huffington Post - June 8, 2016 Category: Science Source Type: news

Aspirin Lowers Your Chances of a Heart Attack. But It ’s Not Safe for Everyone
As medications go, aspirin is often considered a wonder drug. Its pain-reliving, inflammation-taming powers can treat headaches, minor aches and pains and even lower the risk of heart disease, stroke and possibly even dementia. But all of those benefits may come at a price, according to the latest study to analyze aspirin’s risks and benefits, especially for people who take the drug as a way to prevent having a first heart event. In a study published in JAMA, researchers led by Dr. Sean Zheng at King’s College London found that the risks of aspirin — primarily of bleeding in the stomach and intestinal tra...
Source: TIME: Health - January 23, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthytime Heart Disease Source Type: news

Aspirin Lowers Your Chances of a Heart Attack. But It ’s Not Safe for Everyone, a New Study Says
As medications go, aspirin is often considered a wonder drug. Its pain-relieving, inflammation-taming powers can treat headaches, minor aches and pains and even lower the risk of heart disease, stroke and possibly even dementia. But all of those benefits may come at a price, according to the latest study to analyze aspirin’s risks and benefits, especially for people who take the drug as a way to prevent having a first heart event. In a study published in JAMA, researchers led by Dr. Sean Zheng at King’s College London found that the risks of aspirin — primarily of bleeding in the stomach and intestinal tr...
Source: TIME: Health - January 23, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthytime Heart Disease Source Type: news

As some hail new antibody treatment for Alzheimer ’s, safety and benefit questions persist
In a packed San Francisco conference room with a celebratory atmosphere, upbeat company representatives and scientists yesterday presented detailed clinical trial data on the first Alzheimer’s treatment shown to clearly, albeit modestly, slow the disease’s normal cognitive decline. The antibody therapy has buoyed a field marked by decades of failures. Now, it appears to be on the cusp of being greenlit by the U.S. Food and Drug Administration (FDA). Yet other researchers warn of potential risks, including brain swelling and brain hemorrhages that were linked to the recently disclosed deaths of two trial participants wh...
Source: Science of Aging Knowledge Environment - December 1, 2022 Category: Geriatrics Source Type: research

Making Sense of Nutraceuticals in China
The Chinese nutraceutical market is considered the third largest in the world after the US and Japan, or the fourth largest if Europe is counted as a single market.Despite strong fundamentals and high rates of annual growth, though, the Chinese market remains some way from realizing its true potential. Its evolution is muddied by ambiguities around what nutraceuticals actually are and how they should be managed.The result has been polarization between over-zealous regulation of so-called health foods, and a grey market where products have skirted approval procedures through questionable positioning or by exploiting alterna...
Source: EyeForPharma - February 10, 2017 Category: Pharmaceuticals Authors: Marc Yates Source Type: news

Hookah smoking raises cardiovascular risk comparable to traditional cigarette smoking, study finds
This study is believed to be the first to investigate the effects of hookah smoking on stiffening of the arteries. Studies have shown that as cigarette use continues to decline, hookah smoking is rising, especially among youth and particularly among college students.“We know that flavored tobacco products are frequently the first kind of tobacco product used by youth,” Rezk-Hanna said. “One of the major issues with hookah is the fact that the tobacco is flavored with fruit, candy and alcohol flavors, making hookah the most popular flavored tobacco produc t among this audience.”According to the Food and Drug Admini...
Source: UCLA Newsroom: Health Sciences - August 2, 2018 Category: Universities & Medical Training Source Type: news

Pharmacotherapy of obesity: clinical treatments and considerations.
Abstract Obesity is a world-wide epidemic associated with significant morbidity and mortality which costs billions of dollars per year. The associated related conditions are many and include heart disease, stroke, type II diabetes mellitus, sleep apnea and certain types of cancer. Given that it is a multifactorial problem, the treatments must also address the numerous causes associated with the development of obesity. The neurohormonal regulation of feeding and energy is a complex system often necessitating modification through more than 1 pathway to achieve weight loss. Therefore, in addition to lifestyle changes...
Source: The American Journal of the Medical Sciences - April 1, 2013 Category: Journals (General) Authors: Holes-Lewis KA, Malcolm R, O'Neil PM Tags: Am J Med Sci Source Type: research

You Can't Take a Vacation From Sleep Apnea
Americans took 2.1 billion trips for business or pleasure in 2014. That's a lot of time away from the comforts of home. For people with sleep apnea, travel creates the dilemma of what to do about their CPAP (continuous positive air pressure) machines: Do I lug it with me or try to struggle through sleep without it? Fortunately, there's good news with more choices in treatments and devices to help apnea sufferers sleep soundly while on the road. You don't want to be tired during your business trip. Sleep apnea is a disorder where breathing stops and starts during sleep (sometimes up to hundreds of times per night) because ...
Source: Healthy Living - The Huffington Post - January 27, 2016 Category: Consumer Health News Source Type: news

Evolution of Pharmacological Obesity Treatments: Focus on Adverse Side‐Effect Profiles
ABSTRACT Pharmacotherapy directed toward reducing body weight may provide benefits for both curbing obesity and lowering the risk of obesity‐associated co‐morbidities. However, many weight loss medications have been withdrawn from the market due to serious adverse effects. Examples include pulmonary hypertension (aminorex), cardiovascular toxicity, e.g. flenfluramine‐induced valvopathy, stroke (phenylpropanolamine), excess non‐fatal cardiovascular events (sibutramine), and neuro‐psychiatric issues (rimonabant ‐ approved in Europe, but not in the US). This negative experience has helped mold the current drug dev...
Source: Diabetes, Obesity and Metabolism - March 1, 2016 Category: Endocrinology Authors: Andrew J. Krentz, Ken Fujioka, Marcus Hompesch Tags: REVIEW ARTICLE Source Type: research

Phases in development of an interactive mobile phone-based system to support self-management of hypertension
Inger Hallberg,1,11 Charles Taft,1,11 Agneta Ranerup,2,11 Ulrika Bengtsson,1,11 Mikael Hoffmann,3,10 Stefan Höfer,4 Dick Kasperowski,5 Åsa Mäkitalo,6 Mona Lundin,6 Lena Ring,7,8 Ulf Rosenqvist,9 Karin Kjellgren1,10,11 1Institute of Health and Care Sciences, 2Department of Applied Information Technology, University of Gothenburg, Gothenburg, 3The NEPI Foundation, Linköping, Sweden; 4Department of Medical Psychology, Innsbruck Medical University, Innsbruck, Austria; 5Department of Philosophy, Linguistics and Theory of Science, 6Department of Education, Communication and Learning, University of Gothenburg...
Source: Integrated Blood Pressure Control - May 6, 2014 Category: Cardiology Tags: Integrated Blood Pressure Control Source Type: research

It Won't Be Easy to Reduce the Salt in Our Diets
You might want to take the latest campaign to reduce our daily consumption of sodium with a grain of salt. On second thought, maybe you shouldn't. Officials at the Food and Drug Administration (FDA) have announced two-year and 10-year voluntary goals to slowly lower the average daily intake of sodium by Americans. The reason is simple. Excess sodium consumption can lead to higher blood pressure and other health problems. Despite the obvious motivation, nutritionists interviewed by Healthline say these goals may not be easy to obtain. Our propensity for packaged foods and dining out at restaurants has created a salty h...
Source: Healthy Living - The Huffington Post - June 8, 2016 Category: Consumer Health News Source Type: news

What FDA ’s new sodium guidelines could look like in practice
With nine out of 10 U.S. adults and children consuming too much sodium, the U.S. Food and Drug Administration (FDA) has released draft proposed voluntary guidelines to encourage companies to significantly reduce sodium in processed and restaurant foods by 2020. Some of the recommended changes may be eye-opening for patients who don ’t closely monitor their sodium intake. The need to decrease sodium consumption High sodium intake has a direct correlation to high blood pressure, which leads to heart disease and stroke —the most common causes of death in the U.S., contributing to more than 1,000 deaths per day. “...
Source: AMA Wire - June 8, 2016 Category: Journals (General) Authors: Troy Parks Source Type: news

Hypertension's 3 Dilemmas and 3 Solutions: Pharmacology of the Kidney in Hypertension
Abstract: The Hypertension Community has 3 conflicting dilemmas: a goal systolic pressure of 120 mm Hg or less (the SPRINT Trials), 40% of our 60,000,000 hypertensives still sustain blood pressures above 140/90 mm Hg, and our most potent antihypertensive drug minoxidil sits on the sidelines, imprisoned in the Food and Drug Administration's Black Box designation. My solutions to these dilemmas are: (1) review of the facts of our most potent antihypertensive drug minoxidil which is essentially free of toxicity, (2) treatment focus on the fundamental cause of high blood pressure, that is excess dietary sodium and, (3) prevent...
Source: Journal of Cardiovascular Pharmacology - March 1, 2017 Category: Cardiology Tags: Commentary Source Type: research

Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis.
Abstract Psoriasis vulgaris is a common, heterogeneous, chronic inflammatory skin disease characterized by thickened, red, scaly plaques and systemic inflammation. Psoriasis is also associated with multiple comorbid conditions, such as joint destruction, cardiovascular disease, stroke, hypertension, metabolic syndrome, and chronic kidney disease. The discovery of IL-17-producing T cells in a mouse model of autoimmunity transformed our understanding of inflammation driven by T lymphocytes and associations with human inflammatory diseases, such as psoriasis. Under the regulation of IL-23, T cells that produce high l...
Source: Journal of Immunology - September 6, 2018 Category: Allergy & Immunology Authors: Hawkes JE, Yan BY, Chan TC, Krueger JG Tags: J Immunol Source Type: research

‘We’re Not As Healthy As We Should Be.’ Fitbit CEO James Park Discusses New AFib Detection Partnership With Bristol-Myers Squibb-Pfizer
“We’re not as healthy as we should be.” That’s what Fitbit CEO and co-founder James Park said at Thursday’s TIME 100 Health Summit, where MSNBC anchor Stephanie Ruhle interviewed him about the company’s future in the health care space, the impact of wearables and just how active Fitbit’s 30 million active users really are. Ruhle talked with Park about Fitbit’s position as one of the first major wearables company to have gone public, one that led the charge in terms of mass market adoption but has lost ground to competitors offering more advanced wearable devices, as well as ...
Source: TIME: Health - October 17, 2019 Category: Consumer Health News Authors: Patrick Lucas Austin Tags: Uncategorized fitness HealthSummit19 technology Source Type: news